These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4625586)

  • 21. Excretion of trans- 9 -tetrahydrocannabinol and its metabolites in intact and bile duct-cannulated rats.
    Turk RF; Dewey WL; Harris LS
    J Pharm Sci; 1973 May; 62(5):737-40. PubMed ID: 4705677
    [No Abstract]   [Full Text] [Related]  

  • 22. Film coating theory and practice.
    Banker GS
    J Pharm Sci; 1966 Jan; 55(1):81-9. PubMed ID: 5918657
    [No Abstract]   [Full Text] [Related]  

  • 23. [EFFECT OF DOSAGE FORMS ON THE RESORPTION OF DRUGS].
    FINHOLT P
    Sven Farm Tidskr; 1964 May; 68():345-51 CONCL. PubMed ID: 14146538
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical Species.
    Chen XQ; Ziemba T; Huang C; Chang M; Xu C; Qiao JX; Wang TC; Finlay HJ; Salvati ME; Adam LP; Gudmundsson O; Hageman MJ
    J Pharm Sci; 2018 May; 107(5):1352-1360. PubMed ID: 29317226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basics of Compounding: Compounding Films.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new formulation concept for drugs with poor water solubility for parenteral application.
    Jürgens K; Müller BW
    Pharmazie; 2005 Sep; 60(9):665-70. PubMed ID: 16222865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preformulation studies. II. Stability of drug substances in solid pharmaceutical systems.
    Tingstad J; Dudzinski J
    J Pharm Sci; 1973 Nov; 62(11):1856-60. PubMed ID: 4758086
    [No Abstract]   [Full Text] [Related]  

  • 29. Permeability enhancing lipid-based co-solvent and SEDDS formulations of SQ641, an antimycobacterial agent.
    Mutyam SK; Bejugam NK; Parish HJ; Reddy VM; Bogatcheva E; Shankar GN
    Pharm Dev Technol; 2015; 20(5):598-607. PubMed ID: 24946795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sterile topical dosage forms. I. Laboratory phase.
    Polli GP; Fong DT; Shoop CE
    J Pharm Sci; 1972 Jul; 61(7):1078-80. PubMed ID: 4625585
    [No Abstract]   [Full Text] [Related]  

  • 31. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of recent memory by marihuana and THC in rhesus monkeys.
    Zimmerberg B; Glick SD; Jarvik ME
    Nature; 1971 Oct; 233(5318):343-5. PubMed ID: 5000625
    [No Abstract]   [Full Text] [Related]  

  • 33. Emulsion formulations of testosterone for nasal administration.
    Ko KT; Needham TE; Zia H
    J Microencapsul; 1998; 15(2):197-205. PubMed ID: 9532525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
    Guzmán HR; Tawa M; Zhang Z; Ratanabanangkoon P; Shaw P; Gardner CR; Chen H; Moreau JP; Almarsson O; Remenar JF
    J Pharm Sci; 2007 Oct; 96(10):2686-702. PubMed ID: 17518357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification and properties of iron preparations.
    Müller A
    Arzneimittelforschung; 1974 Jun; 24(6):880-3. PubMed ID: 4408174
    [No Abstract]   [Full Text] [Related]  

  • 37. Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle.
    Wagner DS; Johnson CE; Cichon-Hensley BK; DeLoach SL
    Am J Health Syst Pharm; 2003 Jun; 60(12):1268-70. PubMed ID: 12845924
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of an aqueous injection of ketoprofen.
    Singhai AK; Jain S; Jain NK
    Pharmazie; 1997 Feb; 52(2):149-51. PubMed ID: 9122274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Does fenfluramine mean a real advance in the treatment of obesity?].
    Chruściel M; Chruściel TL
    Postepy Hig Med Dosw; 1973; 27(3):365-90. PubMed ID: 4198497
    [No Abstract]   [Full Text] [Related]  

  • 40. Biopharmaceutical aspects of the design of steroidal dosage forms.
    Short MP; Rhodes CT
    Pharmazie; 1973 Aug; 28(8):509-13. PubMed ID: 4593892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.